Health & Biotech
Bioxyne highlights risks of unregulated psychedelic use
Dimerix strikes $120m licensing deal for kidney drug in Middle East
ASX Health Stocks: EMV’s AI algo shows promise, and Telix submits new FDA application
ScoPo’s Powerplays: ASX health stocks fall as Sonic cuts FY24 profit guidance
ASX Health Stocks: FDA gives nod to PYC, and Althea’s new JV puts cannabis drinks in US bottle shops
How Micro-X’s game-changing tech is transforming the X-ray market
Check Up: Alzheimer’s is ‘preventable’, so here’s what you must do; and recent ASX biotech winners
ASX Health Stocks: Health app firm MedAdvisor guides the market to record year and maiden profit
Aroa meets guidance, aims for cashflow positivity in FY25
ASX Health Stocks: Telix says TLX592 shows promise in prostate cancer battle
‘Outstanding milestone’: FDA grants PharmAust orphan drug designation for monepantel
Long Shortz with Optiscan Imaging: Life-saving deal with Mayo Clinic years in the making
ASX Health Stocks: Memphasys’ Felix triumphs over traditional sperm-prepping methods for IVF
Cardiex’s CONNEQT Pulse included on the US Blood Pressure Validated Device List
ScoPo’s Powerplays: ASX health stocks rise, Mach7 eyes cashflow positive in FY24
Immutep’s clinical trials are advancing rapidly; here are the next catalysts for investors
InteliCare anticipates positive impact from increased Budget spending on aged care
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
